• Je něco špatně v tomto záznamu ?

Activity of novel inhibitors of Staphylococcus aureus biofilms

SG. Woo, SY. Lee, SM. Lee, KH. Lim, EJ. Ha, YB. Eom,

. 2017 ; 62 (2) : 157-167. [pub] 20161118

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17010570

Staphylococcus aureus is one of the most important pathogens causing chronic biofilm infections. These are becoming more difficult to treat owing to drug resistance, particularly because S. aureus biofilms limit the efficacy of antimicrobial agents, leading to high morbidity and mortality. In the present study, we screened for inhibitors of S. aureus biofilm formation using a natural product library from the Korea Chemical Bank (KCB). Screening by crystal violet-based biomass staining assay identified hit compounds. Further examination of antibiofilm properties of these compounds was conducted and led to the identification of celastrol and telithromycin. In vitro, both celastrol and telithromycin were toxic to planktonic S. aureus and also active against a clinical methicillin-resistant S. aureus (MRSA) isolate. The effect of the compounds on preformed biofilms of clinical MRSA isolates was evaluated by confocal laser scanning microscopy (CLSM), which revealed the absence of typical biofilm architecture. In addition, celastrol and telithromycin inhibited the production of extracellular protein at selected sub-MIC concentrations, which revealed the reduced extracellular polymeric substance (EPS) secretion. Celastrol exhibited greater cytotoxicity than telithromycin. These data suggest that the hit compounds, especially telithromycin, could be considered novel inhibitors of S. aureus biofilm. Although the mechanisms of the effects on S. aureus biofilms are not fully understood, our data suggest that telithromycin could be a useful adjuvant therapeutic agent for S. aureus biofilm-related infections.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17010570
003      
CZ-PrNML
005      
20170321103331.0
007      
ta
008      
170321s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-016-0485-4 $2 doi
035    __
$a (PubMed)27864779
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Woo, Seung-Gyun $u Department of Medical Science, College of Medical Sciences, Soonchunhyang University, 22 Soonchunhyang-ro, Shinchang-myeon, Asan-si, Chungcheongnam-do, 31538, Republic of Korea.
245    10
$a Activity of novel inhibitors of Staphylococcus aureus biofilms / $c SG. Woo, SY. Lee, SM. Lee, KH. Lim, EJ. Ha, YB. Eom,
520    9_
$a Staphylococcus aureus is one of the most important pathogens causing chronic biofilm infections. These are becoming more difficult to treat owing to drug resistance, particularly because S. aureus biofilms limit the efficacy of antimicrobial agents, leading to high morbidity and mortality. In the present study, we screened for inhibitors of S. aureus biofilm formation using a natural product library from the Korea Chemical Bank (KCB). Screening by crystal violet-based biomass staining assay identified hit compounds. Further examination of antibiofilm properties of these compounds was conducted and led to the identification of celastrol and telithromycin. In vitro, both celastrol and telithromycin were toxic to planktonic S. aureus and also active against a clinical methicillin-resistant S. aureus (MRSA) isolate. The effect of the compounds on preformed biofilms of clinical MRSA isolates was evaluated by confocal laser scanning microscopy (CLSM), which revealed the absence of typical biofilm architecture. In addition, celastrol and telithromycin inhibited the production of extracellular protein at selected sub-MIC concentrations, which revealed the reduced extracellular polymeric substance (EPS) secretion. Celastrol exhibited greater cytotoxicity than telithromycin. These data suggest that the hit compounds, especially telithromycin, could be considered novel inhibitors of S. aureus biofilm. Although the mechanisms of the effects on S. aureus biofilms are not fully understood, our data suggest that telithromycin could be a useful adjuvant therapeutic agent for S. aureus biofilm-related infections.
650    _2
$a antibakteriální látky $x farmakologie $7 D000900
650    _2
$a biofilmy $x účinky léků $x růst a vývoj $7 D018441
650    _2
$a biologické přípravky $x farmakologie $7 D001688
650    _2
$a genciánová violeť $7 D005840
650    _2
$a rychlé screeningové testy $7 D057166
650    _2
$a ketolidy $x farmakologie $7 D048628
650    _2
$a methicilin rezistentní Staphylococcus aureus $x účinky léků $x fyziologie $7 D055624
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a plankton $x účinky léků $x růst a vývoj $7 D010933
650    _2
$a knihovny malých molekul $x farmakologie $7 D054852
650    _2
$a Staphylococcus aureus $x účinky léků $x fyziologie $7 D013211
650    _2
$a triterpeny $x farmakologie $7 D014315
655    _2
$a časopisecké články $7 D016428
700    1_
$a Lee, So-Yeon $u Department of Medical Science, College of Medical Sciences, Soonchunhyang University, 22 Soonchunhyang-ro, Shinchang-myeon, Asan-si, Chungcheongnam-do, 31538, Republic of Korea.
700    1_
$a Lee, So-Min $u Department of Biomedical Laboratory Science, College of Medical Sciences, Soonchunhyang University, 22 Soonchunhyang-ro, Shinchang-myeon, Asan-si, Chungcheongnam-do, 31538, Republic of Korea.
700    1_
$a Lim, Kyoung-Hee $u Department of Biomedical Laboratory Science, College of Medical Sciences, Soonchunhyang University, 22 Soonchunhyang-ro, Shinchang-myeon, Asan-si, Chungcheongnam-do, 31538, Republic of Korea.
700    1_
$a Ha, Eun-Ju $u Department of Biomedical Laboratory Science, College of Medical Sciences, Soonchunhyang University, 22 Soonchunhyang-ro, Shinchang-myeon, Asan-si, Chungcheongnam-do, 31538, Republic of Korea.
700    1_
$a Eom, Yong-Bin $u Department of Medical Science, College of Medical Sciences, Soonchunhyang University, 22 Soonchunhyang-ro, Shinchang-myeon, Asan-si, Chungcheongnam-do, 31538, Republic of Korea. omnibin@sch.ac.kr. Department of Biomedical Laboratory Science, College of Medical Sciences, Soonchunhyang University, 22 Soonchunhyang-ro, Shinchang-myeon, Asan-si, Chungcheongnam-do, 31538, Republic of Korea. omnibin@sch.ac.kr.
773    0_
$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 62, č. 2 (2017), s. 157-167
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27864779 $y Pubmed
910    __
$a ABA008 $b online $c sign $y a $z 0
990    __
$a 20170321 $b ABA008
991    __
$a 20170321103602 $b ABA008
999    __
$a ok $b bmc $g 1195193 $s 971286
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 62 $c 2 $d 157-167 $e 20161118 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
LZP    __
$a Pubmed-20170321

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...